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Abstract. Blood samples of 218 children ages 2–14 years old with confirmed malaria in hospitals across Ghana were
tested for dengue virus exposure. We detected dengue-specific immunoglobulin M (IgM) antibodies in 3.2% of the
children, indicating possible coinfection, and IgG antibodies in 21.6% of them, which suggests previous exposure.
Correlates of exposure are discussed.
INTRODUCTION
Misdiagnosis of febrile illnesses as malaria remains a chal-
lenge in Africa,1 despite evidence that the proportion of fevers
attributable to malaria has decreased over the last two
decades.2 Although urbanization has suppressed the global
malaria burden,3 it has also driven the emergence of many
arboviral diseases, including dengue fever,4,5 and newly
revised estimates of the global dengue burden suggest that it
is probably significantly larger than previously estimated.6,7
Recent seroprevalence surveys have uncovered dengue expo-
sure throughout sub-Saharan Africa,7 and west Africa has been
identified as a potential hotspot for transmission because of the
existence of the Aedes mosquito vector, historical arbovirus
transmission, rapid urbanization with inadequate sanitation,
and low clinical knowledge of flavivirus infections.8
Malaria transmission is endemic in Ghana, and healthcare
practitioners at many urban healthcare facilities presump-
tively diagnose malaria using clinical algorithms. Between
2001 and 2006, 47% of healthcare facility visits by children
and 37% of healthcare facility visits by adults resulted in a
clinical diagnosis of malaria.9 Because of resource constraints,
fewer than 10% of malaria diagnoses were confirmed by
blood examination between 2007 and 2011.10 Data from 2013
suggest that less than one-third of all national malaria diagno-
ses are currently confirmed by blood analysis, and clinical
staff diagnose approximately 40–50% of all sick children—
and about 40% of all outpatients—with malaria.11 In a recent
study of 605 feverish children who sought care at a hospital in
Accra, it was revealed that only 11% tested positive for
malaria by microscopy after 80% had been diagnosed with
malaria and treated with antimalarials.12 These findings show
that the etiology of febrile illness includes much more than
Plasmodium infections and underscore the urgent need to
begin examining the possible role of other pathogens.
This study was implemented as a pilot for a broader popula-
tion study of the etiology of febrile illness in Ghana and began
by testing for evidence of dengue exposure in 218 children
with laboratory-confirmed malaria.
METHODS
This study investigated the possible role of dengue virus
(DENV) in febrile illness by testing archived plasma samples
that were collected from children ages 2–14 years old who
tested positive for malaria at local health facilities in three
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Figure 1. The three urban centers comprising the study area
in Ghana. 2010 population census estimates for Accra, Kintampo,
and Navrongo were 2.07 million, 42,957, and approximately 27,000,
respectively.18
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ecological zones of Ghana: Ledzokuku-Krowor Municipal
Assembly Hospital, Kpeshie, in the coastal savannah Greater
Accra Region containing the national capital Accra; Kintampo
Municipal Hospital, Kintampo, in the tropical-forested transi-
tion zone of Brong-Ahafo Region; and War Memorial Hospital,
Navrongo, in the Upper East Region’s dry southern savannah
climate belt (Figure 1). This study was approved by the respec-
tive Institutional Review Boards of the Ghana Health Service,
Navrongo Health Research Centre, Kintampo Health Research
Centre, Noguchi Memorial Institute for Medical Research (Uni-
versity of Ghana), and the University of Miami. A parent or
guardian gave written informed consent for each child who par-
ticipated in the study. The samples were collected from 2011 to
2014 as part of a study at the University of Ghana investigating
erythrocyte invasion mechanisms of Plasmodium falciparum,
and therefore, only malaria-positive samples were available.
The inclusion criteria for enrollment were (1) resident in
the respective community for at least the preceding 6 months,
(2) age between 2 and 14 years old, (3) positive for malaria by
rapid diagnostic test (RDT), and (4) having a parent or guard-
ian who willingly signed the study consent form for the child’s
participation and answered a short questionnaire. Venous
blood was collected into heparinized tubes and centrifuged,
and plasma was harvested and stored at −80°C until use.
Dengue-specific immunoglobulin M (IgM) and IgG were
detected in plasma samples using the Capture DxSelect enzyme-
linked immunosorbent assay (ELISA; Focus Diagnostics,
Inc., Cypress, CA). The sensitivity of the IgM DxSelect Kit
assessed by assaying well-characterized sera was reported as
96% (73 of 76), with specificity pooled from multiple sites
reported as 97% (296 of 306) and a 27% (9 of 33) cross-
reactivity rate with other flavivirus infections.13 The sensitivity
of the IgG DxSelect Kit for well-characterized sera was 96%
(76 of 79), with pooled specificity reported as 93% (253 of 271)
and a 61% (20 of 33) cross-reactivity with other flaviviruses.14
In addition, viral RNA was extracted from the plasma samples
using the QIAamp Viral RNA Mini Kit (Qiagen N.V., Venlo,
The Netherlands) followed by detection of specific DENV
serotypes 1–4 (DENV-1 to -4) using the AgPath-ID One-Step
Reverse Transcriptase Polymerase Chain Reaction (RT-PCR)
Kit (Applied Biosystems, Foster City, CA) on an ABI 7300
Fast Dx Real-Time PCR Instrument (Applied Biosystems) as
described previously.15
RESULTS
Demographic characteristics of the study population are
presented in Table 1. Of 218 plasma samples tested, 7 (3.2%)
were positive for dengue-specific IgM, whereas 47 (21.6%)
were positive for dengue-specific IgG. The IgG response dif-
fered significantly across study sites (c2 = 8.29, P = 0.016),
with a lower rate observed in Kintampo compared with Accra
Table 1
Individual sociodemographic, behavioral, and clinical characteristics of 218 children stratified by three study sites in Ghana: Accra, Kintampo,
and Navrongo
Characteristic
Total sample Accra Kintampo Navrongo
Frequency
Percentage or
mean (SE) Frequency
Percentage or
mean (SE) Frequency
Percentage or
mean (SE) Frequency
Percentage or
mean (SE)
Dependent measures 218 100 42 19.3 94 43.1 82 37.6
IgM response 7 3.2 1 2.4 1 1.1 5 6.1
IgG response* 47 21.6 10 23.8 12 12.8 25 30.5
Independent measures 218 100 42 19.3 94 43.1 82 37.6
Sociodemographic
Sex is male 114 52.3 25 59.5 51 54.3 38 46.3
Age (years) 5.7 (0.20) 6.4 (0.51) 5.5 (0.31) 5.4 (0.28)
Mother has no education* 62 28.4 6 14.3 49 52.1 7 8.5
Owned by parent or guardian
Cement block house* 90 41.3 17 40.5 54 57.4 19 23.2
Thatched house* 120 55.0 2 4.8 54 57.4 64 78.0
Car* 24 11.0 9 21.4 9 9.6 6 7.3
Television* 132 60.6 38 90.5 46 48.9 48 58.5
Radio 189 86.7 38 90.5 81 86.2 70 85.4
Farm* 155 71.1 12 28.6 83 88.3 60 73.2
Refrigerator* 79 36.2 36 85.7 15 16.0 28 34.1
Behavioral
Antimalarial drug taken in last 2 weeks 32 14.7 9 21.4 10 10.6 13 15.9
Traditional/herbal medicine used 23 10.6 3 7.1 6 6.4 14 17.1
Daily bed net use* 155 71.1 16 38.1 68 72.3 71 86.6
Clinical
Symptoms
Fever* 206 94.5 36 85.7 88 93.6 82 100
Headache 175 80.3 34 81.0 76 80.9 65 79.3
Nausea* 125 57.3 19 45.2 46 48.9 60 73.2
Chills* 80 36.7 34 81.0 46 48.9 0 0
Joint pain 39 17.9 8 19.0 22 23.4 9 11.0
Diarrhea 39 17.9 6 14.3 21 22.3 12 14.6
Convulsions 8 3.7 4 9.5 2 2.1 2 2.4
Jaundice 8 3.7 2 4.8 5 5.3 1 1.2
Other: cough* 23 10.6 0 0 12 12.8 11 13.4
Other: abdominal pain* 49 22.5 2 4.8 8 8.5 39 47.6
Parasite density (/mL; N = 201)* 76,298 (8,059) 20,725 (3,409) 139,458 (18,111) 44,005 (3,853)
Hemoglobin (g/dL; N = 214) 10.2 (0.12) 10.7 (0.28) 10.1 (0.17) 10.0 (0.18)
*Statistically significant (P £ 0.05) differences between study sites from c2 (for categorical measures) or F (for continuous measures) tests.
498 STOLER AND OTHERS
and Navrongo. Kintampo’s geographic location results in
fewer travelers from neighboring countries, which may be
important if local dengue exposure is associated with imported
cases. No dengue viral RNA was detected by real-time PCR,
suggesting that none of the study participants had an acute
dengue infection. In dengue infections, IgM is detected about
5 days after the onset of illness and may persist for about
90 days, whereas IgG is detected after 10–15 days and may
persist for years. The observed IgM prevalence is, thus, likely
caused by exposure toward the latter end of the 90-day window,
at which point most children would have already cleared the
virus. The observed IgG prevalence may be attributable to the
same dengue wave or some other previous exposure. Because
all PCR results were negative and the plaque reduction neutral-
ization test (PRNT) was not available at the time in Ghana,
our seroprevalence results are limited by the sensitivity and
specificity of the ELISAs and the potential for cross-reactivity
with antibodies for other flaviviruses in the plasma samples.
Although antibodies from yellow fever and influenza vaccina-
tions may present cross-reactivity issues for the IgG ELISA,14
yellow fever vaccination coverage is high among Ghana’s
youth (although no reliable data exist), and we would have
expected much higher rates of IgG response if vaccinations
were significantly skewing our results.
To evaluate predictors of positive IgM and IgG antibody
responses in the study cohort, we implemented multilevel
logistic regression models using the GLIMMIX procedure in
SAS 9.3 (Cary, NC) to control for three study sites in Ghana.
Independent measures from Table 1 were introduced in sepa-
rate blocks of sociodemographic, behavioral, and biomedical
measures; any model terms that presented convergence issues
caused by lack of variation were removed. In the full model
presented in Table 2, only two measures were statistically
significantly associated with higher odds of an IgM response:
lower daily bed net use (P = 0.018) and higher parasite density
(P = 0.030). This result may be spurious, caused by the low
number of positive IgM responses detected per study site, and
reflected in higher −2 residual log pseudolikelihood for this
model. Daily bed net use and parasite density were negatively
related, with daily bed net users averaging two times the
parasite density as non-users (88,497/mL versus 43,914/mL;
F = 6.24, P = 0.013). Mean parasite density was higher for
seven IgM-positive children relative to the rest of the sample,
but the difference was not statistically significant.
We only assessed sociodemographic predictors of 47 IgG
responses because current symptoms and health-seeking
behaviors would not be indicative of previous exposure to
DENV (i.e., more than 90 days ago). As presented in Table 2,
these cases were less likely to come from parents who owned
a cement house (P = 0.019) or farm (P = 0.008). This result is
more intuitive, because DENV transmission is typically driven
by the ubiquitous presence of water-holding containers in the
Table 2
b-Coefficients and SEs for random intercept models assessing the association between demographics, symptoms, and parasitemia on prevalence of
dengue-specific IgM and IgG antibodies among Ghanaian children
Characteristics
IgM
Sociodemographic factors
(N = 218)
Clinical and behavioral factors
(N = 199)
Full model
(N = 199)
IgG sociodemographic factors
(N = 218)
b SE b SE b SE b SE
Intercept −3.32 1.67 −6.55 4.01 −6.58 5.20 −1.48 0.83
Sociodemographic measures
Sex is male −1.06 0.89 −2.28 1.43 0.54 0.37
Age (years) −0.15 0.17 −0.39 0.31 0.11 0.06
Mother has no education −0.72 1.13 −1.12 2.08 0.51 0.45
Owned by parent or guardian
Cement block house −0.96 1.19 −3.61 2.46 −1.12* 0.47
Thatched house 1.72 1.25 0.10 2.23 0.30 0.52
Car −1.14 0.74
Television −0.01 1.06 −1.08 1.71 0.24 0.47
Radio −0.08 0.59
Farm −0.20 0.99 0.96 1.92 −1.25* 0.47
Refrigerator 1.10 1.14 0.70 1.97 0.27 0.51
Behavioral/biomedical measures
Antimalarial drug taken in last 2 weeks 1.41 1.19 1.59 1.60
Traditional/herbal medicine used 0.46 1.13 0.27 1.84
Daily bed net use −2.42* 1.06 −4.27* 1.79
Symptoms
Headache −0.20 1.05 0.72 1.39
Nausea −0.42 0.99 −0.33 1.26
Chills −0.98 1.49 −0.99 1.97
Joint pain 0.67 1.25 0.91 1.49
Diarrhea 0.22 1.20 0.41 1.60
Convulsions
Jaundice
Other: cough 1.53 1.13 1.19 1.88
Other: abdominal pain 1.82 1.17 1.98 1.70
Parasite density (/mL; N = 201) 8.23 E–6* 3.49 E–6 1.10 E–5* 5.10 E–6
Hemoglobin (g/dL; N = 214) 0.28 0.31 0.60 0.44
Model diagnostics
–2 Res log pseudolikelihood 1,518.72 1,444.32 1,765.41 1,070.89
Generalized c2 212.48 133.29 100.59 211.41
*Statistical significance (P < 0.05).
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urban environment (as both household objects and refuse);
higher-quality housing would be expected to protect against
dengue transmission by limiting the Aedes vectors’ access to
residents in the home. The vast majority of these children have
lived in a single home and typically spend little time outside of
their community, thus implicating local exposure.
CONCLUSION
Our findings highlight the complexity of febrile illnesses in
Ghana by revealing previous dengue exposure in 21.6% of
218 children and recent exposure in 3.2% of children. This
may be the first seroprevalence survey in Ghana for dengue
exposure, which is increasingly being recognized as a neglected
tropical disease in west Africa.16,17 We observed dengue expo-
sure in an unlikely population—confirmed malaria cases—
which is probably the tip of the proverbial iceberg for local
dengue fever epidemiology. Our study sample is precisely the
opposite population of febrile illness patients who we would
normally screen for active dengue infection, because we
would assume that laboratory-confirmed malaria patients
have been properly diagnosed. Given that the local dengue
fever burden probably remains obscured by misdiagnosed
malaria cases, the prevalence of DENV (and potentially,
other flaviviruses) in malaria-negative febrile illness patients
is likely to be higher.
The epidemiological profile of infectious diseases remains
cloudy in west Africa and demands a more detailed assess-
ment of the local viral fever baseline. Improved clinical
awareness, surveillance, and diagnostic testing of febrile illness
present a substantial opportunity to improve population health
and deploy healthcare resources more efficiently throughout
the region.
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